TABLE 2.
Prevalence and Severity of Diabetic Retinopathy and Macular Edema
| Characteristic | Total Diabetes
Sample (N = 778), n (%) |
White
(N = 153), n (%) |
Black
(N = 289), n (%) |
Hispanic
(N = 235), n (%) |
Chinese
(N = 101), n (%) |
P Value* |
|---|---|---|---|---|---|---|
| No retinopathy | 520 (66.8) | 115 (75.2) | 183 (63.3) | 147 (62.6) | 75 (74.3) | |
| Retinopathy | 258 (33.2) | 38 (24.8) | 106 (36.7) | 88 (37.4) | 26 (25.7) | .01 |
| Minimal | 116 (14.9) | 22 (14.4) | 48 (16.6) | 37 (15.7) | 9 (8.9) | |
| Early-moderate | 112 (14.4) | 12 (7.8) | 46 (15.9) | 42 (17.9) | 12 (11.9) | |
| Severe-proliferative | 30 (3.9) | 4 (2.6) | 12 (4.2) | 9 (3.8) | 5 (5.0) | |
| No macular edema | 694 (91.0) | 146 (97.3) | 248 (88.9) | 208 (89.3) | 92 (91.1) | |
| Macular edema present | 69 (9.0) | 4 (2.7) | 31 (11.1) | 25 (10.7) | 9 (8.9) | .007 |
| CSME | 43 (5.6) | 3 (2.0) | 21 (7.5) | 16 (6.9) | 3 (3.0) | |
| Vision-threatening retinopathy | 60 (7.9) | 7 (4.5) | 26 (9.3) | 20 (8.7) | 7 (6.9) | .28 |
N = number at risk; n = number with retinopathy endpoint; % = prevalence.
*
P value based on χ2 test, comparing racial/ethnic differences for any retinopathy, macular edema, and vision-threatening retinopathy.